Today: 23 March 2026
Browse Category

Stock Market 31 December 2025

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital shares rose about 1% to $24.31 premarket Wednesday after a non-binding term sheet proposed combining its cloud unit with Ekso Bionics to form ChronoScale. Applied Digital would own 97% of the new company if the deal closes, expected in the first half of 2026. Investors await further deal details and the Jan. 7 earnings report. The stock closed Tuesday at $24.08, down 2.9%.
B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold shares edged up 0.1% to $4.56 in premarket trading Wednesday, tracking a 0.9% drop in spot gold as profit-taking and higher futures margins weighed on bullion. Gold remains up about 65% for the year. B2Gold reported third-quarter production of 254,369 ounces and all-in sustaining costs of $1,479 per ounce. U.S. markets faced thin holiday trading and lower index futures ahead of the final 2025 session.
31 December 2025
Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour shares hovered near $5 premarket Wednesday after Fairfax Financial disclosed it bought about 15.7 million shares across two classes in late December. Fairfax and affiliates now own over 30 million Class A shares, or 16.1% of that class. The purchases totaled roughly $71 million at prices between $4.36 and $4.73. Investors await Under Armour’s next quarterly update in early 2026.
31 December 2025
BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai shares fell 3.2% to $5.50 in premarket trading after the company postponed a shareholder vote on doubling its authorized common stock to Jan. 22. CEO Kevin McAleenan told investors the company is running low on authorized shares. The board is seeking more support for the proposal, which would raise the limit to 1 billion shares. The Ask Sage acquisition is expected to close late Q4 2025 or early Q1 2026.
31 December 2025
Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab shares rose 0.9% to $71.07 in premarket trading Wednesday after closing at $70.45 Tuesday. Director Edward H. Frank sold 2,500 shares at $77.39 and gifted 5,000 shares, according to an SEC filing. The company recently won an $816 million U.S. Space Development Agency contract for 18 missile-tracking satellites. Rocket Lab completed its final 2025 launch on Dec. 21, deploying a Japanese satellite.
31 December 2025
BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote

BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote

BitMine Immersion reported holding 4.11 million ether tokens and $13.2 billion in crypto and cash as of Dec. 28. Shares were little changed in premarket trading after the update. The company urged investors to vote ahead of a Jan. 15 shareholder meeting on governance and capital-raising. BitMine said it had 408,627 ether staked and is planning a validator network launch in 2026.
D-Wave Quantum (QBTS) stock today: what’s moving shares in early premarket trade

D-Wave Quantum (QBTS) stock today: what’s moving shares in early premarket trade

D-Wave Quantum shares held near $26.25 in quiet premarket trading Wednesday, capping a year with a 213% gain despite recent volatility. The company plans two January events, including a CES appearance, as traders eye updates on bookings and commercial traction. About 12% of D-Wave’s float is sold short. Next earnings are expected in March.
India fires two Pralay missiles in rapid salvo off Odisha as DRDO flags “imminent” induction

India fires two Pralay missiles in rapid salvo off Odisha as DRDO flags “imminent” induction

India’s DRDO fired two Pralay short-range ballistic missiles in rapid succession off Odisha on Wednesday during user evaluation trials, the defence ministry said. Both missiles met all flight objectives, with Indian Air Force and Army officials present. DRDO chief Samir V. Kamat said the results indicate imminent readiness for induction. Tracking sensors and telemetry confirmed the launches’ success.
31 December 2025
Rivian stock slips in premarket as Tesla delivery report looms on year-end session

Rivian stock slips in premarket as Tesla delivery report looms on year-end session

Rivian shares slipped 0.7% to $19.46 in premarket trading Wednesday after a 5.2% drop Tuesday. Tesla and Lucid also traded lower ahead of Tesla’s quarterly delivery report due Friday. Thin year-end trading and the upcoming New Year’s Day market holiday have heightened focus on 2026 EV demand. No new filings or product news moved the stocks in early trade.
American Airlines stock dips in premarket as winter storm fallout keeps airlines in focus

American Airlines stock dips in premarket as winter storm fallout keeps airlines in focus

American Airlines shares slipped 0.1% to $15.31 in premarket trading Wednesday after a 1.25% gain Tuesday. Winter Storm Ezra disrupted U.S. travel, causing nearly 6,000 delays and 751 cancellations, with airlines waiving change fees. Oil prices fell over 15% in 2025, easing jet fuel costs. Investors await American’s next earnings update, tentatively set for Jan. 22, 2026.
31 December 2025
NIO stock dips in premarket as China’s 2026 EV trade-in subsidies take shape

NIO stock dips in premarket as China’s 2026 EV trade-in subsidies take shape

NIO’s U.S.-listed shares fell about 3% to $5.33 in premarket trading Wednesday, after rising 3% Tuesday. China advanced 62.5 billion yuan in funding for its 2026 consumer trade-in program, keeping EV subsidies in place but changing subsidy rules. Analysts say the new structure may favor higher-priced models and add uncertainty for mass-market demand. Investors await January delivery data for further signals.
Opendoor stock today: OPEN edges up in premarket as traders watch jobless claims, rates

Opendoor stock today: OPEN edges up in premarket as traders watch jobless claims, rates

Opendoor shares edged up 0.1% to $5.84 in premarket trading Wednesday, following a 0.2% gain Tuesday. Trading remains volatile with short interest at 15% of float and meme-stock attention persisting. The company recently acquired HomeBuyer.com and named Christy Schwartz CFO, effective Jan. 1. Weekly U.S. jobless claims data is due at 8:30 a.m. ET ahead of Thursday’s market holiday.
31 December 2025
Tesla stock slips in premarket after Tesla posts downbeat delivery consensus ahead of Friday report

Tesla stock slips in premarket after Tesla posts downbeat delivery consensus ahead of Friday report

Tesla shares slipped 0.3% in premarket trading Wednesday after the company published a consensus estimate showing fourth-quarter deliveries of 422,850 vehicles, below other analyst tallies. The move comes ahead of Tesla’s official quarterly report due Friday. The company rarely releases such forecasts publicly. Tesla closed Tuesday at $454.43, down 1.13%.

Stock Market Today

  • Humana (HUM) Shares Fall 35% Amid Regulatory Concerns, Valuation Gap Emerges
    March 22, 2026, 8:17 PM EDT. Humana (NYSE: HUM) shares have dropped about 35% over the past year, despite generating $129.7 billion in revenue and a $1.2 billion net income. The stock closed at $169.90, showing modest recent gains but marking a significant 17% intrinsic discount against a fair value estimate of $212.87. Regulatory scrutiny around Medicare Advantage, a key growth driver for insurers, has intensified, pressuring profit margins and increasing compliance risks. Investors face a crucial choice: bet on potential undervaluation or factor in challenges from tougher regulation and margin pressures. Analysts highlight a cautious outlook, urging review of growth, margins, and capital returns in the current environment. This valuation gap underscores the uncertainty surrounding Humana's path in a tightening regulatory landscape.
Go toTop